FBXO11 and neoplasm: Given the tumor-suppressive functions of FBXO11 in hematologic malignancies, we queried whole-exome sequencing data from the Memorial Sloan Kettering Cancer Center (MSK) IMPACT-HEME study for FBXO11 mutations.